Estrella Immunopharma (ESLA) Prepaid Assets (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Prepaid Assets of $229794.0 for Q1 2026, down 56.05% year-over-year from $522795.0 in Q1 2025, and down 21.48% quarter-over-quarter from $292673.0 in Q4 2025.
Estrella Immunopharma (ESLA) Prepaid Assets (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Prepaid Assets for 6 consecutive years, with $229794.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 56.05% year-over-year to $229794.0; the TTM figure through Mar 2026 stood at $229794.0 (down 56.05% YoY), while the FY2025 annual figure was $292673.0, down 59.57% from the prior year.
- Prepaid Assets eased to $229794.0 in Q1 2026 per ESLA's latest filing, from $292673.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $723861.0 in Q4 2024 and bottomed at $11625.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $258543.6 across 5 years, with a median of $229794.0 in 2026.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 91.52% — and 2023, when it surged 3351.6%.
- Estrella Immunopharma's Prepaid Assets stood at $11625.0 in 2022, then soared by 3351.6% to $401248.0 in 2023, then jumped by 80.4% to $723861.0 in 2024, then sank by 59.57% to $292673.0 in 2025, then dropped by 21.48% to $229794.0 in 2026.
- Business Quant data shows ESLA's Prepaid Assets at $229794.0 in Q1 2026, $292673.0 in Q4 2025, and $396901.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 178,011.00 |
| Mar 31, 2026 | 229,794.00 |
| Dec 31, 2025 | 292,673.00 |
| Sep 30, 2025 | 396,901.00 |
| Jun 30, 2025 | 163,933.00 |
| Mar 31, 2025 | 522,795.00 |
| Dec 31, 2024 | 723,861.00 |
| Sep 30, 2024 | 437,642.00 |
| Jun 30, 2024 | 288,761.00 |
| Mar 31, 2024 | 406,110.00 |
| Dec 31, 2023 | 401,248.00 |
| Sep 30, 2023 | 138,767.00 |
| Jun 30, 2023 | 94,675.00 |
| Mar 31, 2023 | 52,500.00 |
| Dec 31, 2022 | 11,625.00 |
| Sep 30, 2022 | 87,000.00 |
| Jun 30, 2022 | 40,541.00 |
| Mar 31, 2022 | 106,416.00 |
| Dec 31, 2021 | 137,166.00 |
| Sep 30, 2021 | 7,966.00 |